Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(20%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_2
1
10%
Ph not_applicable
8
80%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (11.1%)
N/A8 (88.9%)

Trials by Status

withdrawn110%
recruiting220%
completed770%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10